Innovations in pharmacotherapy for stress urinary incontinence

International Urogynecology Journal

Volumn 14, Issue 6, 2003, Pages 367-372

  Cannon, Tracy W ^a   Yoshimura, Naoki ^a   Chancellor, Michael B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Duloxetine; Serotonin; Stress urinary incontinence; Urethra

Indexed keywords

2,5 DIMETHOXY 4 IODOPHENYLLISOPROPYLAMINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; DOXEPIN; DULOXETINE; EPHEDRINE; ESTROGEN; IMIPRAMINE; MIDODRINE; NORADRENALIN UPTAKE INHIBITOR; NORFENEFRINE; NORFLUOXETINE; PHENYLPROPANOLAMINE; PLACEBO; PROPRANOLOL; SEROTONIN 2 AGONIST; SEROTONIN UPTAKE INHIBITOR; THIONISOXETINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VENLAFAXINE;

AIRWAY RESISTANCE; ANXIETY DISORDER; BEHAVIOR THERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; FATIGUE; FEMALE; FOOD AND DRUG ADMINISTRATION; HEADACHE; HEART ARRHYTHMIA; HEART FAILURE; HEART PALPITATION; HUMAN; HYPERTENSION; INSOMNIA; MENORRHAGIA; MUSCLE WEAKNESS; NAUSEA; NONHUMAN; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SOMNOLENCE; STRESS INCONTINENCE; STROKE; TREMOR; VERTIGO;

EID: 0347286885     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-003-1093-9     Document Type: Review

References (40)

1. Retzky SS, Rogers RMJ (1995) Urinary incontinence in women. Clin Symp 47:2-32
2. Norton PA (1996) Etiology of genuine stress incontinence. In: Brubaker LT, Saclarides TJ (eds0 The female pelvic floor: disorders of function and support. Davis, Philadelphia, pp 153-157
3. Peschers U, Schaer G, Anthuber C, Delancey JO, Schuessler B (1996) Changes in vesical neck mobility following vaginal delivery. Obstet Gynecol 88:1001-1006
4. Thom DH, van den Eeden SK, Brown JS (1997) Evaluation of parturition and other reproductive variables as risk factors for urinary incontinence in later life. Obstet Gynecol 90:983-989
5. Meyer S, Schreyer A, DeGrandi P, Hohlfeld P (1998) The effects of birth on urinary continence mechanisms and other pelvic-floor characteristics. Obstet Gynecol 92:613-618
6. Sampselle CM, Miller JM, Mims BL, DeLancey JO, Ashton-Miller JA, Antonakos CL (1998) Effect of pelvic muscle exercise on transient incontinence during pregnancy and after birth. Obstet Gynecol 91:406-412
7. Snooks SJ, Badenock DF, Tiptaft RC, Swash M (1985) Perineal nerve damage in genuine stress incontinence: an electrophysiology study. Br J Urol 57:422-426
8. Snooks SJ, Swash M, Henry MM, Setchell M (1986) Risk factors in childbirth causing damage to the pelvic floor. Int J Colored Dis 1:20-24
9. Smith ARB, Hosker GL, Warrell DW (1989) The role of pudendal nerve damage in the aetiology of genuine stress incontinence in women. Br J Obstet Gynecol 96:29-32
10. Allen RE, Hosker GL, Smith ARB, Warrell DW. Pelvic floor damage and childbirth: a neurophysiological study Brit J Obstet Gynecol 1990; 97:770-779
11. Handa VL, Harris TA, Ostergard DR (1996) Protecting the pelvic floor: Obstetric management to prevent incontinence and pelvic organ prolapse Obst Gynecol 88:470-478
12. Wilson L, Brown JS, Shin GP, Luc KD, Subak LL (2001) Annual direct costs of urinary incontinence. Obstet Gynecol 98:398-406
13. Rovner ES, Wein AJ (2001) Drug treatment of voiding dysfunction. In: Cardozo L, Staskin D (eds) The textbook of female urology and urogynecology. Isis Medical Media, London, pp 357-407
14. Diokno A, Taub M (1975) Ephedrine in treatment of urinary incontinence. Urol 5:624
15. Lose G, Lindholm D (1994) Clinical and urodynamic effects of norfenefrine in women with stress incontinence. Urol Int 39:298
16. Lose G, Diernoes E, Rix P (1989) Does medical therapy cure female stress incontinence. Urol Int 44:25
17. Awad SA, Downie J, Kirulita J (1978) Alpha adrenergic agents in urinary disorders of the proximal urethra. Br J Urol 50:332
18. Stewart B, Borowsky L, Montague D (1976) Stress incontinence: conservative therapy with sympathomimetic drugs. J Urol 115:558
19. Kiesswetter H, Hennrich R, English M (1983) Clinical and Pharmacologic therapy of stress incontinence. Urol Int 38:58
20. Barlett DM, Wein AJ (1991) Voiding dysfunction: diagnosis, classification and management. In: Gillenwater JY, Grayhack JT, Howards ST, Duckett JW (eds) Adult and pediatric urology, 2nd edn. Mosby, St Louis, 1001-1099
21. Gleason D, Reilly R, Bottaccinin M et al. (1974) The urethral continence zone and its relation to stress incontinence. J Urol 112:81
22. Kaisary AU (1984) Beta adrenoceptor blockade in the treatment of female stress urinary incontinence. J Urol 90:351
23. Hodgson BJ, Dumas S, Bolling DR et al. (1978) Effect of oestrogen on sensitivity of rabbit bladder and urethra to phenylephrine. Invest Urol 16:67
24. Levin RM, Shofer FS, Wein AJ (1980) Oestrogen-induced alterations in the autonomic responses of the rabbit urinary bladder. J Pharmacol Exp Ther 214:614
25. Larsson B, Andersson K, Batra S et al. (1984) Effects of estradiol on norepinephrine-induced contraction, alpha adrenoreceptor number and norepinephrine content in the female rabbit urethra. J Pharmacol Exp Ther 229:557
26. Fellenius E, Hedberg R, Holmberg E et al. (1980) Functional and metabolic effects of terbutaline and propranolol in fast and slow contraction skeletal muscle in vitro. Acta Physiol Scand 109:89
27. Thor KB, Hisamitsu T, de Groat WC (1990) Unmasking of a neonatal somatovesical reflex in adult cats by the serotonin autoreceptor agonist 5-methoxy-N,N-dimethyltryptamine. Brain Res Dev Brain Res 54:35-42
28. Espey MJ, Downie JW, Fine A (1992) Effect of 5-HT receptor and adrenoceptor antagonists on micturition in conscious cats. Eur J Pharmacol 221:167-170
29. Danuser H, Thor KB (1996) Spinal 5-HT2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat. Br J Pharmacol 118:150-154
30. Krier J, Thor KB, de Groat WC (1979) Effects of clonidine on the lumbar sympathetic pathways to the large intestine and urinary bladder of the cat. Eur J Pharmacol 59:47-53
31. Pederson E, Torring J, Klemar B (1980) Effect of the alpha-adrenergic blocking agent thymoxamine on the neurogenic bladder and urethra. Acta Neurol Scand 61:107-114
32. Gajewski J. Downie JW. Awad SA (1984) Experimental evidence for a central nervous system site of action in the effect of alpha-adrenergic blockers on the external urinary sphincter. J Urol132:403-409
33. Downie JW, Bialik GJ (1988) Evidence for a spinal site of action of clonidine on somatic and viscerosomatic reflex activity evoked on the pudendal nerve in cats. J Pharmacol Exp Ther 246:352-358
34. Downie JW, Espey MJ, Gajewski JB (1991) Alpha 2-adrenoceptors not imidazole receptors mediate depression of a sacral spinal reflex in the cat. Eur J Pharmacol 195:301-304
35. Thor KB, Katofiasc MA (1995) Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose anesthetized female cat. J Pharmacol Exp Ther 274:1014-1024
36. 1 adrenergic receptor antagonist prazosin. J Urol 153: 1308-1312
37. Katofiasc MA. Nissen J. Audia JE. Thor KB (2002) Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats. Life Sci 71:1227-1236
38. Norton PA, Zinner NR, Yalcin I, Bump RC (2002) Duloxetine Urinary Incontinence Study Group. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 187:40-48
39. Zinner N, Dmochowski R, Miklos J, Norton P, Yalcin I, Bump R (2002) Duloxetine versus placebo in the treatment of stress urinary incontinence (SUI). Neurourol Urodyn 21:383-384
40. van Kerrebroeck P, Abrams P, Lange R et al. (2003) Duloxetine vs. placebo in the treatment of European and Canadian women with stress urinary incontinence (abstract). Eur Urol Suppl 2:29